News | January 23, 2014

Telestroke Offers Cost-Saving Benefits


January 23, 2014 — Research published in the American Journal of Managed Care indicated using telemedicine to deliver stroke care, or telestroke, appears to be cost-effective for society. 
 
Telestroke robots allow stroke patients in facilities with no neurology specialists to receive real-time consultation from neurologists in other areas via computer. 
 
"This study shows that a hub-and-spoke telestroke network is not only cost-effective from the societal perspective, but it's cost-saving,” said neurologist Bart Demaerschalk, M.D., director of the Mayo Clinic Telestroke Program, and the lead investigator of the telestroke cost effectiveness study. “We can assess medical services, like telemedicine, in terms of the net costs to society for each year of life gained."
 
The study estimates a telestroke system consisting of a single hub and seven spoke hospitals may result in the appropriate use of more clot-busting drugs and catheter-based interventional procedures, with more stroke patients discharged home independently. Despite upfront and maintenance expenses, the entire network of hospitals may realize a total cost savings.
 
When comparing a rurally located patient receiving routine stroke care at a community hospital, a patient treated in the context of a telestroke network incurred $1,436 lower costs and gained 0.02 quality-adjusted life-years over a lifetime.
Benefits of telestroke include reduced resource use for services such as inpatient rehabilitation, nursing homes and caregiver time. 
 
The study was conducted by researchers at Mayo Clinic, Georgia Health Sciences University, Analysis Group.
 
Mayo Clinic in Arizona serves as the hub in a network of 13 spoke centers. More than 4,000 emergency consultations between Mayo stroke neurologists and physicians at spoke centers have taken place since the telestroke program began. Mayo Clinic Telestroke has hubs in Arizona, Florida and Minnesota, and serves more than 20 healthcare institutions in seven states.
 
For more information: www.mayoclinic.org

Related Content

News | Stroke

March 3, 2025 — Genentech, a member of the Roche Group, recently announced that the U.S. Food and Drug Administration ...

Home March 04, 2025
Home
News | Stroke

Feb. 6, 2025 — New findings from the DiVERT Stroke clinical study showed women spent less time in the hospital, saw ...

Home February 07, 2025
Home
News | Stroke

Feb. 5, 2025 — Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment ...

Home February 07, 2025
Home
News | Stroke

Jan. 29, 2025 — Researchers at Ochsner Health, led by Hernan Bazan, MD, DFSVS, FACS, have developed a predictive model ...

Home January 30, 2025
Home
News | Stroke

Nov. 16, 2024 Anthos Therapeutics, Inc.recently presented new data at the American Heart Association (AHA) Scientific ...

Home November 18, 2024
Home
News | Stroke

Oct. 24, 2024 – Royal Philips and Medtronic Neurovascular have announced a strategic advocacy partnership. Delivering ...

Home October 24, 2024
Home
News | Stroke

Sept. 10, 2024 — Royal Philips and the World Stroke Organization (WSO) have published a policy paper calling for a ...

Home September 10, 2024
Home
News | Stroke

Aug. 23, 2024 — A team led by researchers at Yale School of Medicine has created a deep learning model that can ...

Home August 26, 2024
Home
News | Stroke

According to research published in Stroke, the peer-reviewed scientific journal of the American Stroke Association, one ...

Home August 09, 2024
Home
News | Stroke

June 7, 2024 — Access to thrombectomy should be expanded to include patients who experience basilar artery occlusion ...

Home June 07, 2024
Home
Subscribe Now